Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study.
Alkaline Phosphatase
/ blood
Cause of Death
Cohort Studies
Disease Progression
Disease-Free Survival
Enzyme Replacement Therapy
/ methods
Female
Follow-Up Studies
Humans
Hypophosphatasia
/ blood
Infant
Internationality
Kaplan-Meier Estimate
Male
Pregnancy
Retrospective Studies
Risk Assessment
Severity of Illness Index
Survival Analysis
Time Factors
alkaline phosphatase
craniosynostosis
invasive ventilation
metabolic bone disease
rickets
survival
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
30
08
2018
revised:
16
01
2019
accepted:
29
01
2019
pubmed:
14
4
2019
medline:
16
4
2020
entrez:
14
4
2019
Statut:
ppublish
Résumé
To report clinical characteristics and medical history data obtained retrospectively for a large cohort of pediatric patients with perinatal and infantile hypophosphatasia. Medical records from academic medical centers known to diagnose and/or treat hypophosphatasia were reviewed. Patients born between 1970 and 2011 with hypophosphatasia and any of the following signs/symptoms at age <6 months were eligible: vitamin B6-dependent seizures, respiratory compromise, or rachitic chest deformity (NCT01419028). Patient demographics and characteristics, respiratory support requirements, invasive ventilator-free survival, and further complications of hypophosphatasia were followed for up to the first 5 years of life. Forty-eight patients represented 12 study sites in 7 countries; 13 patients were alive, and 35 were dead (including 1 stillborn). Chest deformity, respiratory distress, respiratory failure (as conditioned by the eligibility criteria), failure to thrive, and elevated calcium levels were present in >70% of patients between birth and age 5 years. Vitamin B6-dependent seizures and respiratory distress and failure were associated significantly (P < .05) with the risk of early death. Serum alkaline phosphatase activity in all 41 patients tested (mean [SD]: 18.1 [15.4] U/L) was below the mean lower limit of normal of the reference ranges of the various laboratories (88.2 U/L). Among the 45 patients with relevant data, 29 had received respiratory support, of whom 26 had died at the time of data collection. The likelihood of invasive ventilator-free survival for this cohort decreased to 63% at 3 months, 54% at 6 months, 31% at 12 months, and 25% at 5 years. Patients with perinatal or infantile hypophosphatasia and vitamin B6-dependent seizures, with or without significant respiratory distress or chest deformities, have high morbidity and mortality in the first 5 years of life. ClinicalTrials.gov: NCT01419028.
Identifiants
pubmed: 30979546
pii: S0022-3476(19)30139-8
doi: 10.1016/j.jpeds.2019.01.049
pii:
doi:
Substances chimiques
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
116-124.e4Investigateurs
Michael Beck
(M)
Linda DiMeglio
(L)
Paul Wuh-Liang Hwu
(P)
Peter Simm
(P)
Jill Simmons
(J)
Joel Steelman
(J)
Robert D Steiner
(RD)
Andrea Superti-Furga
(A)
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.